Research Article

The Association of Olfactory Dysfunction, Frailty, and Mortality Is Mediated by Inflammation: Results from the InCHIANTI Study

Table 3

Characteristics of 1035 participants according to survival status.

Dead ()Alive ()

Demographics & lifestyle habits, (%), mean (SD), or median (IQR)
Age (years)80 (7)72 (5)<.001
Sex (female)200 (51)377 (59).014
Education (years)5 (3)6 (3)<.001
Living alone206 (52)199 (31)<.001
Smoking (former and current)172 (44)251 (39).152
Dietary intake
Alcohol (g/day/kg)0.10 (0–0.26)0.10 (0–0.32).021
Total protein intake (g/day/kg)1.14 (0.32)1.11 (0.32).262
Total lipid intake (g/day/kg)0.97 (0.30)0.96 (0.32).582
Available carbohydrate intake (g/day/kg)3.82 (1.26)3.67 (1.20).066
Fibre (g/day/kg)0.29 (0.09)0.29 (0.08).654
Energy intake (kcal/day/kg)29.08 (8.33)28.40 (8.37).227
Comorbid conditions, (%) or median (IQR)
Diabetes52 (13)62 (10).082
Heart failure46 (12)13 (2)<.001
Chronic pulmonary disease63 (16)26 (4)<.001
Parkinson’s disease21 (5)6 (1)<.001
Stroke44 (11)16 (2)<.001
Hip fracture24 (6)14 (2).002
Peripheral arterial disease86 (22)35 (5)<.001
Malignancy28 (7)36 (6).353
Olfactory dysfunction249 (63)341 (53).001
Frailty90 (23)21 (3)<.001
Charlson Comorbidity index1 (0-2)0 (0-1)<.001
Medications, (%), mean (SD), or median (IQR)
Neuroleptics17 (4)16 (2).143
Selective serotonin reuptake inhibitors11 (3)5 (1).017
ACE inhibitors72 (18)69 (11).001
Antiplatelets65 (16)48 (7)<.001
Anticoagulants11 (3)2 (1).001
Benzodiazepines81 (21)92 (14).010
Loop diuretics55 (14)30 (5)<.001
Corticosteroids11 (3)7 (1).050
Biohumoral, physical, and cognitive parameters, (%) or
Glomerular filtration rate (mL/min)56.4 (19.5)69.5 (17.8)<.001
Total serum proteins (g/dL)7.1 (0.5)7.1 (0.4).680
Interleukin 6 (pg/mL)1.89 (1.14–3.31)1.22 (0.78–1.84)<.001
Hemoglobin (g/dL)13.4 (1.6)13.9 (1.2)<.001
CES-D14 (9)12 (9)<.001
Mini Mental State Examination22 (6)26 (3)<.001
Katz’s activities of daily living5 (1)6 (0)<.001
Body mass index (kg/m2)27.0 (4.3)27.7 (4.0).016